We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
Cap. Flow
+$1.23B
Cap. Flow %
3.55%
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332

Top Buys

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$342M
2
INTC icon
Intel
INTC
+$276M
3
TSM icon
TSMC
TSM
+$237M
4
PG icon
Procter & Gamble
PG
+$178M
5
JPM icon
JPMorgan Chase
JPM
+$170M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$383M
2
OXY icon
Occidental Petroleum
OXY
+$321M
3
PYPL icon
PayPal
PYPL
+$316M
4
SPGI icon
S&P Global
SPGI
+$145M
5
DDOG icon
Datadog
DDOG
+$133M

Sector Composition

Rank Sector Weight
1 Technology 26.57%
2 Healthcare 17.95%
3 Financials 9.89%
4 Industrials 9.61%
5 Consumer Discretionary 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMNL
2501
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$5K ﹤0.01%
1,080
GFAI icon
2502
Guardforce AI
GFAI
$9.93M
$4K ﹤0.01%
448
-55
-11% -$676
PZG icon
2503
Paramount Gold Nevada
PZG
$93.5M
$4K ﹤0.01%
13,700
-19,400
-59% -$7.69K
SINT icon
2504
SiNtx Technologies
SINT
$9.92M
$4K ﹤0.01%
1
MCOM
2505
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
$4K ﹤0.01%
+1
New +$5.28K
ACOR
2506
DELISTED
Acorda Therapeutics
ACOR
$4K ﹤0.01%
740
+20
+3% +$167
MITO
2507
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$4K ﹤0.01%
13,700
-1,700
-11% -$484
CPHI icon
2508
China Pharma Holdings
CPHI
$52.7M
$3K ﹤0.01%
46
-1
-2% -$99
CRBP icon
2509
Corbus Pharmaceuticals
CRBP
$168M
$3K ﹤0.01%
+560
New +$3.95K
JFU
2510
9F Inc
JFU
$3K ﹤0.01%
565
-145
-20% -$1.73K
TANH icon
2511
Tantech Holdings
TANH
$6.15M
$3K ﹤0.01%
19
-17
-47% -$4.24K
YCBD icon
2512
cbdMD
YCBD
$5.25M
$3K ﹤0.01%
42
-7
-14% -$1K
AUMN
2513
DELISTED
Golden Minerals Company
AUMN
$3K ﹤0.01%
532
-60
-10% -$439
NMTR
2514
DELISTED
9 Meters Biopharma
NMTR
$3K ﹤0.01%
+650
New +$3.22K
CFMS
2515
DELISTED
Conformis, Inc. Common Stock
CFMS
$3K ﹤0.01%
660
-268
-29% -$1.86K
ZVO
2516
DELISTED
Zovio Inc. Common Stock
ZVO
$2K ﹤0.01%
12,400
-9,100
-42% -$4.5K
FNHC
2517
DELISTED
FedNat Holding Company Common Stock
FNHC
$2K ﹤0.01%
14,000
-600
-4% -$201
MF
2518
DELISTED
Missfresh Limited American Depositary Shares
MF
$2K ﹤0.01%
600
ABEO icon
2519
Abeona Therapeutics
ABEO
$343M
-552
Closed -$3K
ABTS icon
2520
Abits Group
ABTS
$3.41M
-1,013
Closed -$15K
ABUS icon
2521
Arbutus Biopharma
ABUS
$871M
-64,400
Closed -$175K
ACAD icon
2522
Acadia Pharmaceuticals
ACAD
$4.45B
-16,600
Closed -$234K
ACVA icon
2523
ACV Auctions
ACVA
$1.43B
-48,100
Closed -$315K
AEHL icon
2524
Antelope Enterprise Holdings
AEHL
$10.5M
-5
Closed -$13K
AEHR icon
2525
Aehr Test Systems
AEHR
$2.27B
-10,500
Closed -$79K

Similar funds

Two Sigma Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.

  • Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
  • Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
  • Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
  • Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
  • Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
  • Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
  • Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.